Resource Library


[Industry Voice #20] Roche Pharma on RWE: shifting the landscape of clinical research and healthcare

Real-World Evidence has been used to speed access to new treatment options, especially for rare diseases, and served as a resource to better characterize treatment effects, including those in underrepresented populations. In this episode of Industry Voice our guest, Galina Osina, RWE Lead at Roche will help us analyze the ongoing and future trends of Real-World Data in pharmaceutical research.

Thank you for your request!
Our team will respond to you within 24 hours.